Weekly AI News: Oct 19, 2026 – Oct 25, 2026
The three AI stories that mattered most in the week of Oct 19, 2026 – Oct 25, 2026: what happened, who is affected and how, and why it matters.
Anthropic and Nscale discuss $45B AI contract
What happenedAnthropic and Nscale are negotiating a new AI cloud contract reportedly worth about 450 billion dollars.
Who is affected and howIndustry players in cloud and AI markets would see a shift in competition and pricing; IPO and company valuations may be influenced.
Why it mattersA deal of this scale can reshape market dynamics, investment decisions, and strategic technology choices for users and providers.
OpenAI to Acquire Orchestra Bio to Expand Drug Discovery
What happenedOpenAI acquired Orchestra Bio to expand AI use in life sciences, planning to combine Rosalind-related research with WorkBench to automate and accelerate drug discovery.
Who is affected and howR&D departments in biotech and pharma, and developers using AI in life sciences, will face new tools and integration pathways.
Why it mattersThis moves AI-enabled drug discovery closer to routine deployment, potentially speeding research and changing investment priorities in life sciences.
U.S. Government to Exclude DeepSeek Products
What happenedThe US government publicly ordered the removal of DeepSeek products from federal procurement and IT systems, including third-party implementations.
Who is affected and howFederal agencies and contractors using or integrating DeepSeek-related technologies will need to replace or audit their IT stacks.
Why it mattersThis affects public-sector security and supply chain practices, driving adjustments in procurement and risk management.